Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma.

CONCLUSIONS: This feasibility study suggests IVI improves quality of life and ferritin. Larger adequately powered studies are required to definitively conclude if hemoglobin and blood transfusion changes with IVI. PMID: 30198775 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30198775?dopt=Abstract

Source: Nutrition and Cancer - September 10, 2018 Category: Cancer & Oncology Authors: Ng O, Keeler B, Simpson JA, Madhusudan S, Brookes M, Acheson A Tags: Nutr Cancer Source Type: research